Progyny, Inc. (PGNY) research

Progyny, Inc.
ShareXLinkedInReddit
Sector
Health Care
Last price
$27.38
As of

Progyny, Inc. (PGNY): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-07.

As of . Source: SEC EDGAR filings for PGNY. Method and limitations.

SHARE THIS CARD

Share the PGNY intelligence card

A branded snapshot of PGNY: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion PGNY intelligence card preview
Post to X
LIVE TERMINAL

See PGNY live in the terminal

Track PGNY's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live PGNY terminal, free

Active signals for PGNY

FREE, NO ACCOUNT

Every signal on PGNY, as it fires

You are seeing 5 of 23 signals recorded on PGNY since 2026-05-30.

The five above all landed on 2026-09-06. The other 18 were recorded on 4 other days. 19 of the 23 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in PGNY (2026Q2)

Manager / securityMarket value% portfolioQoQ
CITADEL ADVISORS LLCCUSIP 74340E103 · 2026Q2$51.5M0.01%,
MILLENNIUM MANAGEMENT LLCCUSIP 74340E103 · 2026Q2$12.7M0.00%,
RENAISSANCE TECHNOLOGIES LLCCUSIP 74340E103 · 2026Q2$12.2M0.02%,
Bridgewater Associates, LPCUSIP 74340E103 · 2026Q2$1.5M0.01%,
D. E. Shaw & Co., Inc.CUSIP 74340E103 · 2026Q2$526K0.00%,
TWO SIGMA INVESTMENTS, LPCUSIP 74340E103 · 2026Q2$375K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, PGNY

PGNY against its peers

PGNY's operating margin of 6.6% ranks in the 73rd percentile of 23 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.

MetricPGNYPeer medianPercentilen
Revenue FY1.3B USD959M USD6025
Gross margin23.6%57.3%818
Operating margin6.6%0.4%7323
Net margin4.5%-0.0%7125
Return on equity11.3%0.0%7424
P / E42.1x32.1x6311

Peers (25): MD, SEM, ALHC, XRAY, INSP, NVCR, LMAT, PRVA, ACHC, BKD, ATEC, OMCL, ATRC, AVAH, TMDX, WGS, PNTG, CNMD, AMN, OMDA, CERT, USPH, TNDM, CRVL, IRTC. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (PGNY: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more PGNY signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to PGNYand get the insider, 13F, options, and confluence read in one view.

Open the live PGNY terminal, free